7
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Analyses of lpr-gvhd by adoptive transfer experiments using mrl/lpr-thy-1.1 congenic mice

, , , , &
Pages 217-224 | Received 24 Dec 1993, Published online: 07 Jul 2009

References

  • Andrews BS, Eisenberg RA, Theofilopopulos AN, Izumi S, Wilson CB, McConahey PJ. Spontaneous murine lupus-like syndrome. J Exp Med 1978; 148: 1198–215
  • Theofilopoulos AN, Dixon FJ. Murine model of systemic lupus erythematosus. Adv Immunol 1985; 37: 269–390
  • Morse HC, III, Davidson WF, Yetter RA, Murphy ED, Roths JB, CofFman R. Abnormalities induced by the mutant gene, lpr. J Immunol 1982; 129: 2612–5
  • Davidson WF, Dumont FJ, Bedigan HG, Fowlle BJ, Morse HC., III. Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gld mice. J Immunol 1986; 136: 4075–84
  • Watanabe-Fukunaga R, Brannan CI. Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314–7
  • Lymphoproliferation (lpr) and other single locus model for murine lupus. Immunologic Defects in Laboratory Animals, Murphy. Plenum Publishing Corp, New York 1981; 143–73
  • Fujiwara M, Kariyone A. One way-occurrence of graft-versus-host disease in bone marrow chimeras between con-genic MRL mice. Immunology 1984; 53: 251–6
  • Nakamura T, Ikehara S, Good RA, Inoue S, Sekita K, Maung Maung Oo. Abnormal stem cells in autoimmune-prone mice are responsible for prematue thymic involution. Thymus 1985; 7: 151–60
  • Theofilopoulos AN, Balderas RS, Gozes Y, Aguado MT, Hang L. Association of lpr gene with graft-vs.-host disease-like syndrome. J Exp Med 1985; 162: 1–18
  • Nakagawa T, Nagata N, Hosaka N, Inaba M, Yasumizu R, Ogawa R. Analyses of acute graft-versus-host-like reaction in [MRL/lpr → MRL/ +] chimeric mice using MRL/lpr-Thy-1.1 congenic mice. Cell Immunol 1991; 137: 189–99
  • Julius MH, Simpson E, Herzenberg LA. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol 1973; 3: 645–9
  • Sykes M, Eisenthai A, Sachs DH. Mechanism of protection from graft-vs-host disease in murine mixed allogeneic chimeras. I. Development of a null cell population suppressive of cell-mediated lympholysis responses and derived from the syngeneic bone marrow component. J Immunol 1988; 140: 2903–11
  • Strober S, Palathumpat V, Schwadron R, Herlel-Wulff B. Cloned natural suppressor cells prevent lethal graft-vs-host disease. J Immunol 1987; 138: 699–703
  • Sugiura K, Inaba M, Ogata H, Yasumizu R, Inaba M, Good RA. Wheat germ agglutinin-positive cells in stem cell-enriched fraction of mouse bone marrow have potent natural suppressor activity. Proc Natl Acad Sci 1988; 85: 4824–6
  • Sugiura K, Ikehara S, Inaba M, Haraguchi S, Ogata H, Sardina EE. Enrichment of natural suppressor activity in the fraction of hematopoietic progenitors with interleu-kin 3 receptor-associated antigen. Exp Hematol. 1992; 20: 256–63
  • Allen RD, Marshall JD, Roths JB, Sidman CL. Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an inter pair of molecules. J Exp Med 1990; 172: 1367–75
  • Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233–43
  • Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA. The cDNA structure expression, and chromosomal assignment of the Fas antigen. J Immunol 1992; 148: 1274–9
  • Nagata N, Yasumizu R, Ohnishi Y, Nakagawa T, Inaba M, Ikehara S. Auto-MHC class II-reactive T cell line obtained from MRL/ + mice suffering from Ipr-GVHD. I. Characterization of surface phenotypes, specificities and functions in vitro. Lmmunobiol 1990; 181: 367–78
  • Nagata N, Nakagawa T, Hosaka N, Ikehara S. Auto-MHC class II-reactive T cell line obtained from MRL/ + mice suffering from lpr-GVHD. II. Analyses of functional characteristics of T cell line by in vivo administration. Lmmunobiol 1992; 186: 339–50
  • Matsumoto K, Yoshikai Y, Asano T, Himeno K, Iwasaki A, Nomoto K. Defect in negative selection in lpr donor-derived T cells differentiating in non-lpr host thymus. J Exp Med 1991; 173: 127–36
  • Zhou T, Bluethmann H, Zhang J, Edwards CK, III, Mountz J D. Defective maintenance of T cell tolerance to a superan-tigen in MRL-lpr/lpr mice. J Exp Med 1992; 176: 1063–72
  • Watson ML, Rao JK, Gilkeson GS, Ruiz P, Eicher EM, Pisetsky DS. Genetic analysis of MRL-lpr mice: Relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med 1992; 176: 1645–56
  • Gleichmann E, Pals ST, Rolink AG, Radaszkiewicz T, Gleichmann H. Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunol Today 1984; 5: 324–32
  • Sprent J, Schaefer M, Lo D, Korngold R. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II differences. J Exp Med 1986; 163: 998–1011
  • Sprent J, Schaefer M, Gao E-K, Korngold R. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 difference. J Exp Med 1988; 167: 556–69
  • Parkman R. Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones. J Immunol 1986; 136: 3543–8
  • DeClerck Y, Draper V, Parkman R. Clonal analysis of murine graft-vs-host disease. II. Leukokines that stimulate fibroblast proliferation and collagen synthesis in graft-versus-host disease. J Immunol 1986; 136: 3549–52

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.